@id-tsm58.bsky.social
Ophthalmologic evaluation and clinical outcome in candidemia: a seven-year retrospective multicenter cohort study
✅ Just Accepted
🔗 https://bit.ly/3Z1KcRk
✅ Just Accepted
🔗 https://bit.ly/3Z1KcRk
January 25, 2026 at 5:15 PM
Scynexis has secured FDA Qualified Infectious Disease Product (QIDP) and Fast Track designations for its next-generation antifungal SCY-247, underscoring the drug’s potential to address the escalating global threat of multidrug-resistant fungal infections such as Candida auris. #IDsky
Antifungal Earns FDA QIDP and Fast Track Designations Amid Rising Antifungal Resistance | Contagion Live
Scynexis has secured FDA Qualified Infectious Disease Product (QIDP) and Fast Track designations for its next-generation antifungal SCY-247, underscoring the drug’s potential to address the escalating...
www.contagionlive.com
January 25, 2026 at 5:13 PM
This is great information for both nephrology and infectious disease! #PITT_ID26
Infections After Kidney Transplantation From Donors With Human Immunodeficiency Virus (HIV) to Recipients With HIV
✅ Just Accepted
https://bit.ly/4jNGe8D
✅ Just Accepted
https://bit.ly/4jNGe8D
Infections After Kidney Transplantation From Donors With Human Immunodeficiency Virus (HIV) to Recipients With HIV
Among 198 kidney transplant recipients with HIV, the rate and spectrum of posttransplant infections were similar regardless of donor HIV status. HIV donor-
bit.ly
January 20, 2026 at 5:42 PM
This is great information for both nephrology and infectious disease! #PITT_ID26